Celcuity (CELC)
Develops and prepares to commercialize gedatolisib therapies for advanced breast and prostate cancers.
$80.08
vs last close−4.02 (−4.78%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 114.82% | 56.18M shares | |
|---|---|---|---|
| 289 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 8.80% | 4.31M shares | |
| 8 holders · as of Aug 18, 2026 | |||
| Adds to | 123.62% | ||
48.93M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 123.62%; nothing is left for Other.
13F, as of Jun 30, 2026
289 holders · 56.18M shares · 63 new positions · 174 increased · 81 reduced · 59 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 7.92M | 16.18% | 0 | Aug 14, 2026 |
| Avoro Capital Advisors LLC | 3.40M | 6.95% | +25.0K | Aug 14, 2026 |
| RTW Investments, LP | 3.30M | 6.75% | +265.3K | Aug 14, 2026 |
| Perceptive Advisors LLC | 3.20M | 6.53% | +70.0K | Aug 14, 2026 |
| BlackRock, Inc. | 3.02M | 6.17% | +307.3K | Aug 7, 2026 |
| State Street Corp | 1.96M | 4.00% | +436.6K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 1.87M | 3.83% | +91.2K | Aug 13, 2026 |
| Nea Management Company, LLC | 1.71M | 3.50% | −575.0K | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Baker Bros. Advisors LP | 9.99% | 4.88M | 13G | Jul 16, 2026 |
| Brian F. Sullivan | 9.10% | 4.01M | 13G | Nov 13, 2025 |
| Perceptive Advisors LLC | 6.80% | 3.16M | 13G | Feb 17, 2026 |
| Avoro Capital Advisors LLC | 6.72% | 3.11M | 13G | Feb 17, 2026 |
| Bank of America Corp /DE/ | 6.50% | 3.17M | 13G | Aug 11, 2026 |
| RTW Investments, LP | 6.30% | 3.04M | 13G | May 15, 2026 |
| BlackRock, Inc. | 5.90% | 2.18M | 13G | Feb 4, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 14, 2026 | Baker Bros. Advisors LPother: Former 10% owner | Sale · 2 lots | 3,100,000 | $102.50 | 442,940 |
| May 4, 2026 | Richard E. Bullerdirector | Sale · 6 lots | 9,000 | $140.46 | 6,760 |
| May 4, 2026 | David Dalveydirector | Sale | 25,000 | $140.68 | 65,000 |
| Mar 31, 2026 | Richard E. Bullerdirector | Sale · 2 lots | 3,000 | $110.27 | 6,760 |
| Jan 27, 2026 | David Dalveydirector | Sale | 20,000 | $120.03 | 90,000 |
| Dec 5, 2025 | Richard E. Bullerdirector | Sale · 2 lots | 3,000 | $105.69 | 6,760 |
| Dec 1, 2025 | Richard E. Bullerdirector | Sale | 1,100 | $98.13 | 7,260 |
| Nov 21, 2025 | David Dalveydirector | Sale | 15,000 | $100.00 | 110,000 |
| Nov 20, 2025 | Richard E. Bullerdirector | Sale | 3,900 | $96.73 | 7,260 |
House and Senate disclosures
Not reported.